<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36170200</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>30</Day></DateCompleted><DateRevised><Year>2022</Year><Month>11</Month><Day>02</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>119</Volume><Issue>42</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>18</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>Prevention of ribosome collision-induced neuromuscular degeneration by SARS CoV-2-encoded Nsp1.</ArticleTitle><Pagination><StartPage>e2202322119</StartPage><MedlinePgn>e2202322119</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e2202322119</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.2202322119</ELocationID><Abstract><AbstractText>An overarching goal of aging and age-related neurodegenerative disease research is to discover effective therapeutic strategies applicable to a broad spectrum of neurodegenerative diseases. Little is known about the extent to which targetable pathogenic mechanisms are shared among these seemingly diverse diseases. Translational control is critical for maintaining proteostasis during aging. Gaining control of the translation machinery is also crucial in the battle between viruses and their hosts. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the ongoing COVID-19 pandemic. Here, we show that overexpression of SARS-CoV-2-encoded nonstructural protein 1 (Nsp1) robustly rescued neuromuscular degeneration and behavioral phenotypes in <i>Drosophila</i> models of Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis. These diseases share a common mechanism: the accumulation of aberrant protein species due to the stalling and collision of translating ribosomes, leading to proteostasis failure. Our genetic and biochemical analyses revealed that Nsp1 acted in a multipronged manner to resolve collided ribosomes, abort stalled translation, and remove faulty translation products causative of disease in these models, at least in part through the ribosome recycling factor ABCE1, ribosome-associated quality-control factors, autophagy, and AKT signaling. Nsp1 exhibited exquisite specificity in its action, as it did not modify other neurodegenerative conditions not known to be associated with ribosome stalling. These findings uncover a previously unrecognized mechanism of Nsp1 in manipulating host translation, which can be leveraged for combating age-related neurodegenerative diseases that are affecting millions of people worldwide and currently without effective treatment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Xingjun</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0002-8862-3864</Identifier><AffiliationInfo><Affiliation>Department of Pathology, Stanford University School of Medicine, Stanford, CA 94350.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rimal</LastName><ForeName>Suman</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pathology, Stanford University School of Medicine, Stanford, CA 94350.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tantray</LastName><ForeName>Ishaq</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Pathology, Stanford University School of Medicine, Stanford, CA 94350.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geng</LastName><ForeName>Ji</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Pathology, Stanford University School of Medicine, Stanford, CA 94350.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhurtel</LastName><ForeName>Sunil</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Pathology, Stanford University School of Medicine, Stanford, CA 94350.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khaket</LastName><ForeName>Tejinder Pal</ForeName><Initials>TP</Initials><Identifier Source="ORCID">0000-0001-5605-1307</Identifier><AffiliationInfo><Affiliation>Department of Pathology, Stanford University School of Medicine, Stanford, CA 94350.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wen</ForeName><Initials>W</Initials><Identifier Source="ORCID">0000-0002-6458-1364</Identifier><AffiliationInfo><Affiliation>Department of Pathology, Stanford University School of Medicine, Stanford, CA 94350.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Zhe</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Center for Precision Disease Modeling, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD 21201.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Bingwei</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-5807-7014</Identifier><AffiliationInfo><Affiliation>Department of Pathology, Stanford University School of Medicine, Stanford, CA 94350.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Programs of Neuroscience and Cancer Biology, Stanford University School of Medicine, Stanford, CA 94350.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01NS083417</GrantID><Agency>HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)</Agency><Country/></Grant><Grant><GrantID>R01NS084412</GrantID><Agency>HHS | NIH | National Institute of Neurological Disorders and Stroke (NINDS)</Agency><Country/></Grant><Grant><GrantID>R01AR074875</GrantID><Agency>HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>09</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012333">RNA, Messenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D017361">Viral Nonstructural Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D051057">Proto-Oncogene Proteins c-akt</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.48</RegistryNumber><NameOfSubstance UI="C521592">Nsp1 protein, SARS coronavirus</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.7.48</RegistryNumber><NameOfSubstance UI="D012324">RNA-Dependent RNA Polymerase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="N">Alzheimer Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004330" MajorTopicYN="N">Drosophila</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="N">Parkinson Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051057" MajorTopicYN="N">Proto-Oncogene Proteins c-akt</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012333" MajorTopicYN="N">RNA, Messenger</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012324" MajorTopicYN="Y">RNA-Dependent RNA Polymerase</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012270" MajorTopicYN="Y">Ribosomes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017361" MajorTopicYN="Y">Viral Nonstructural Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Alzheimer&#x2019;s disease</Keyword><Keyword MajorTopicYN="N">Nsp1</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">ribosome collision</Keyword><Keyword MajorTopicYN="N">ribosome-associated quality control</Keyword></KeywordList><CoiStatement>Competing interest statement: B.L. is a cofounder and serves on the Scientific Advisory Board of Cerepeut Inc.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>9</Month><Day>28</Day><Hour>13</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>10</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36170200</ArticleId><ArticleId IdType="pmc">PMC9586304</ArticleId><ArticleId IdType="doi">10.1073/pnas.2202322119</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Balch W. E., Morimoto R. I., Dillin A., Kelly J. W., Adapting proteostasis for disease intervention. Science 319, 916&#x2013;919 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18276881</ArticleId></ArticleIdList></Reference><Reference><Citation>Hipp M. S., Kasturi P., Hartl F. U., The proteostasis network and its decline in ageing. Nat. Rev. Mol. Cell Biol. 20, 421&#x2013;435 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30733602</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartl F. U., Protein misfolding diseases. Annu. Rev. Biochem. 86, 21&#x2013;26 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28441058</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandman O., Hegde R. S., Ribosome-associated protein quality control. Nat. Struct. Mol. Biol. 23, 7&#x2013;15 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4853245</ArticleId><ArticleId IdType="pubmed">26733220</ArticleId></ArticleIdList></Reference><Reference><Citation>Harigaya Y., Parker R., No-go decay: A quality control mechanism for RNA in translation. Wiley Interdiscip. Rev. RNA 1, 132&#x2013;141 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">21956910</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Orazio K. N., Green R., Ribosome states signal RNA quality control. Mol. Cell 81, 1372&#x2013;1383 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8041214</ArticleId><ArticleId IdType="pubmed">33713598</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim K. Q., Zaher H. S., Canary in a coal mine: Collided ribosomes as sensors of cellular conditions. Trends Biochem. Sci. 47, 82&#x2013;97 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8688274</ArticleId><ArticleId IdType="pubmed">34607755</ArticleId></ArticleIdList></Reference><Reference><Citation>Joazeiro C. A. P., Mechanisms and functions of ribosome-associated protein quality control. Nat. Rev. Mol. Cell Biol. 20, 368&#x2013;383 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7138134</ArticleId><ArticleId IdType="pubmed">30940912</ArticleId></ArticleIdList></Reference><Reference><Citation>Sitron C. S., Brandman O., Detection and degradation of stalled nascent chains via ribosome-associated quality control. Annu. Rev. Biochem. 89, 417&#x2013;442 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8258965</ArticleId><ArticleId IdType="pubmed">32569528</ArticleId></ArticleIdList></Reference><Reference><Citation>Howard C. J., Frost A., Ribosome-associated quality control and CAT tailing. Crit. Rev. Biochem. Mol. Biol. 56, 603&#x2013;620 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34233554</ArticleId></ArticleIdList></Reference><Reference><Citation>Inada T., Quality controls induced by aberrant translation. Nucleic Acids Res. 48, 1084&#x2013;1096 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7026593</ArticleId><ArticleId IdType="pubmed">31950154</ArticleId></ArticleIdList></Reference><Reference><Citation>Juszkiewicz S., Hegde R. S., Initiation of quality control during Poly(A) translation requires site-specific ribosome ubiquitination. Mol. Cell 65, 743&#x2013;750.e4 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5316413</ArticleId><ArticleId IdType="pubmed">28065601</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundaramoorthy E., et al. , ZNF598 and RACK1 regulate mammalian ribosome-associated quality control function by mediating regulatory 40S ribosomal ubiquitylation. Mol. Cell 65, 751&#x2013;760.e4 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5321136</ArticleId><ArticleId IdType="pubmed">28132843</ArticleId></ArticleIdList></Reference><Reference><Citation>Juszkiewicz S., Speldewinde S. H., Wan L., Svejstrup J. Q., Hegde R. S., The ASC-1 complex disassembles collided ribosomes. Mol. Cell 79, 603&#x2013;614.e8 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7447978</ArticleId><ArticleId IdType="pubmed">32579943</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto S., Sugiyama T., Yamazaki R., Nobuta R., Inada T., Identification of a novel trigger complex that facilitates ribosome-associated quality control in mammalian cells. Sci. Rep. 10, 3422 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7042231</ArticleId><ArticleId IdType="pubmed">32099016</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao S., von der Malsburg K., Hegde R. S., Listerin-dependent nascent protein ubiquitination relies on ribosome subunit dissociation. Mol. Cell 50, 637&#x2013;648 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3719020</ArticleId><ArticleId IdType="pubmed">23685075</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen P. S., et al. , Protein synthesis. Rqc2p and 60S ribosomal subunits mediate mRNA-independent elongation of nascent chains. Science 347, 75&#x2013;78 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4451101</ArticleId><ArticleId IdType="pubmed">25554787</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu J., et al. , A mouse forward genetics screen identifies LISTERIN as an E3 ubiquitin ligase involved in neurodegeneration. Proc. Natl. Acad. Sci. U.S.A. 106, 2097&#x2013;2103 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2650114</ArticleId><ArticleId IdType="pubmed">19196968</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishimura R., et al. , RNA function. Ribosome stalling induced by mutation of a CNS-specific tRNA causes neurodegeneration. Science 345, 455&#x2013;459 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4281038</ArticleId><ArticleId IdType="pubmed">25061210</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapur M., Monaghan C. E., Ackerman S. L., Regulation of mRNA translation in neurons&#x2014;A matter of life and death. Neuron 96, 616&#x2013;637 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5693308</ArticleId><ArticleId IdType="pubmed">29096076</ArticleId></ArticleIdList></Reference><Reference><Citation>Rimal S., et al. , Inefficient quality control of ribosome stalling during APP synthesis generates CAT-tailed species that precipitate hallmarks of Alzheimer&#x2019;s disease. Acta Neuropathol. Commun. 9, 169 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8522249</ArticleId><ArticleId IdType="pubmed">34663454</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., et al. , MISTERMINATE mechanistically links mitochondrial dysfunction with proteostasis failure. Mol. Cell 75, 835&#x2013;848.e8 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7362879</ArticleId><ArticleId IdType="pubmed">31378462</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S., et al. , Quality-control mechanisms targeting translationally stalled and C-terminally extended poly(GR) associated with ALS/FTD. Proc. Natl. Acad. Sci. U.S.A. 117, 25104&#x2013;25115 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7547246</ArticleId><ArticleId IdType="pubmed">32958650</ArticleId></ArticleIdList></Reference><Reference><Citation>Jan E., Mohr I., Walsh D., A cap-to-tail guide to mRNA translation strategies in virus-infected cells. Annu. Rev. Virol. 3, 283&#x2013;307 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27501262</ArticleId></ArticleIdList></Reference><Reference><Citation>Walsh D., Mohr I., Viral subversion of the host protein synthesis machinery. Nat. Rev. Microbiol. 9, 860&#x2013;875 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7097311</ArticleId><ArticleId IdType="pubmed">22002165</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N., et al. ; China Novel Coronavirus Investigating and Research Team, A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727&#x2013;733 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B., et al. , Clinical characteristics of 82 cases of death from COVID-19. PLoS One 15, e0235458 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7347130</ArticleId><ArticleId IdType="pubmed">32645044</ArticleId></ArticleIdList></Reference><Reference><Citation>Ksiazek T. G., et al. ; SARS Working Group, A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. 348, 1953&#x2013;1966 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12690092</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaki A. M., van Boheemen S., Bestebroer T. M., Osterhaus A. D., Fouchier R. A., Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N. Engl. J. Med. 367, 1814&#x2013;1820 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">23075143</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon D. E., et al. , A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 583, 459&#x2013;468 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7431030</ArticleId><ArticleId IdType="pubmed">32353859</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakagawa K., Makino S., Mechanisms of coronavirus Nsp1-mediated control of host and viral gene expression. Cells 10, 300 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7912902</ArticleId><ArticleId IdType="pubmed">33540583</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamitani W., Huang C., Narayanan K., Lokugamage K. G., Makino S., A two-pronged strategy to suppress host protein synthesis by SARS coronavirus Nsp1 protein. Nat. Struct. Mol. Biol. 16, 1134&#x2013;1140 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2784181</ArticleId><ArticleId IdType="pubmed">19838190</ArticleId></ArticleIdList></Reference><Reference><Citation>Thoms M., et al. , Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2. Science 369, 1249&#x2013;1255 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7402621</ArticleId><ArticleId IdType="pubmed">32680882</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan S., et al. , Nonstructural protein 1 of SARS-CoV-2 is a potent pathogenicity factor redirecting host protein synthesis machinery toward viral RNA. Mol. Cell 80, 1055&#x2013;1066.e6 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833686</ArticleId><ArticleId IdType="pubmed">33188728</ArticleId></ArticleIdList></Reference><Reference><Citation>Schubert K., et al. , SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation. Nat. Struct. Mol. Biol. 27, 959&#x2013;966 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32908316</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendez A. S., et al. , The N-terminal domain of SARS-CoV-2&#xa0;nsp1 plays key roles in suppression of cellular gene expression and preservation of viral gene expression. Cell Rep. 37, 109841 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8481097</ArticleId><ArticleId IdType="pubmed">34624207</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke J. M., St Clair L. A., Perera R., Parker R., SARS-CoV-2 infection triggers widespread host mRNA decay leading to an mRNA export block. RNA 27, 1318&#x2013;1329 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8522697</ArticleId><ArticleId IdType="pubmed">34315815</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee A. K., et al. , SARS-CoV-2 disrupts splicing, translation, and protein trafficking to suppress host defenses. Cell 183, 1325&#x2013;1339.e21 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7543886</ArticleId><ArticleId IdType="pubmed">33080218</ArticleId></ArticleIdList></Reference><Reference><Citation>Vazquez C., et al. , SARS-CoV-2 viral proteins NSP1 and NSP13 inhibit interferon activation through distinct mechanisms. PLoS One 16, e0253089 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8224853</ArticleId><ArticleId IdType="pubmed">34166398</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar A., et al. , SARS-CoV-2 nonstructural protein 1 inhibits the interferon response by causing depletion of key host signaling factors. J. Virol. 95, e0026621 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8316110</ArticleId><ArticleId IdType="pubmed">34110264</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie X., et al. , Multi-organ proteomic landscape of COVID-19 autopsies. Cell 184, 775&#x2013;791.e14 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7794601</ArticleId><ArticleId IdType="pubmed">33503446</ArticleId></ArticleIdList></Reference><Reference><Citation>Harnish J. M., Link N., Yamamoto S., Drosophila as a model for infectious diseases. Int. J. Mol. Sci. 22, 2724 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7962867</ArticleId><ArticleId IdType="pubmed">33800390</ArticleId></ArticleIdList></Reference><Reference><Citation>De Giorgio M. R., Di Noia S., Morciano C., Conte D., The impact of SARS-CoV-2 on skeletal muscles. Acta Myol. 39, 307&#x2013;312 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7783438</ArticleId><ArticleId IdType="pubmed">33458586</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y., et al. , Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc. Natl. Acad. Sci. U.S.A. 103, 10793&#x2013;10798 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1502310</ArticleId><ArticleId IdType="pubmed">16818890</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauritzen I., Pardossi-Piquard R., Bourgeois A., B&#xe9;cot A., Checler F., Does intraneuronal accumulation of carboxyl-terminal fragments of the amyloid precursor protein trigger early neurotoxicity in Alzheimer&#x2019;s disease? Curr. Alzheimer Res. 16, 453&#x2013;457 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30907322</ArticleId></ArticleIdList></Reference><Reference><Citation>Askanas V., Engel W. K., Inclusion-body myositis: Newest concepts of pathogenesis and relation to aging and Alzheimer disease. J. Neuropathol. Exp. Neurol. 60, 1&#x2013;14 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11202170</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin L. W., et al. , Transgenic mice over-expressing the C-99 fragment of betaPP with an alpha-secretase site mutation develop a myopathy similar to human inclusion body myositis. Am. J. Pathol. 153, 1679&#x2013;1686 (1998).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1866341</ArticleId><ArticleId IdType="pubmed">9846957</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y., et al. , Alzheimer&#x2019;s-related endosome dysfunction in Down syndrome is Abeta-independent but requires APP and is reversed by BACE-1 inhibition. Proc. Natl. Acad. Sci. U.S.A. 107, 1630&#x2013;1635 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2824382</ArticleId><ArticleId IdType="pubmed">20080541</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauritzen I., et al. , The &#x3b2;-secretase-derived C-terminal fragment of &#x3b2;APP, C99, but not A&#x3b2;, is a key contributor to early intraneuronal lesions in triple-transgenic mouse hippocampus. J. Neurosci. 32, 16243&#x2013;1655a (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5019353</ArticleId><ArticleId IdType="pubmed">23152608</ArticleId></ArticleIdList></Reference><Reference><Citation>Hung C. O. Y., Livesey F. J., Altered &#x3b3;-secretase processing of APP disrupts lysosome and autophagosome function in monogenic Alzheimer&#x2019;s disease. Cell Rep. 25, 3647&#x2013;3660.e2 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6315085</ArticleId><ArticleId IdType="pubmed">30590039</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwart D., et al. , A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP &#x3b2;-CTFs, not A&#x3b2;. Neuron 104, 256&#x2013;270.e5 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31416668</ArticleId></ArticleIdList></Reference><Reference><Citation>Israel M. A., et al. , Probing sporadic and familial Alzheimer&#x2019;s disease using induced pluripotent stem cells. Nature 482, 216&#x2013;220 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3338985</ArticleId><ArticleId IdType="pubmed">22278060</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciaccio M., et al. , COVID-19 and Alzheimer&#x2019;s disease. Brain Sci. 11, 305 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7997244</ArticleId><ArticleId IdType="pubmed">33673697</ArticleId></ArticleIdList></Reference><Reference><Citation>Masek P., Worden K., Aso Y., Rubin G. M., Keene A. C., A dopamine-modulated neural circuit regulating aversive taste memory in Drosophila. Curr. Biol. 25, 1535&#x2013;1541 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4873318</ArticleId><ArticleId IdType="pubmed">25981787</ArticleId></ArticleIdList></Reference><Reference><Citation>Lambertsson A., The minute genes in Drosophila and their molecular functions. Adv. Genet. 38, 69&#x2013;134 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9677706</ArticleId></ArticleIdList></Reference><Reference><Citation>Deliu L. P., Ghosh A., Grewal S. S., Investigation of protein synthesis in Drosophila larvae using puromycin labelling. Biol. Open 6, 1229&#x2013;1234 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5576084</ArticleId><ArticleId IdType="pubmed">28642244</ArticleId></ArticleIdList></Reference><Reference><Citation>Graber T. E., et al. , Reactivation of stalled polyribosomes in synaptic plasticity. Proc. Natl. Acad. Sci. U.S.A. 110, 16205&#x2013;16210 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3791775</ArticleId><ArticleId IdType="pubmed">24043809</ArticleId></ArticleIdList></Reference><Reference><Citation>Juszkiewicz S., et al. , ZNF598 is a quality control sensor of collided ribosomes. Mol. Cell 72, 469&#x2013;481.e7 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6224477</ArticleId><ArticleId IdType="pubmed">30293783</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha N. K., et al. , EDF1 coordinates cellular responses to ribosome collisions. eLife 9, e58828 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7486125</ArticleId><ArticleId IdType="pubmed">32744497</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan L., et al. , Translation stress and collided ribosomes are co-activators of cGAS. Mol. Cell 81, 2808&#x2013;2822.e10 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8260207</ArticleId><ArticleId IdType="pubmed">34111399</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao S., Hegde R. S., Reconstitution of a minimal ribosome-associated ubiquitination pathway with purified factors. Mol. Cell 55, 880&#x2013;890 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4175178</ArticleId><ArticleId IdType="pubmed">25132172</ArticleId></ArticleIdList></Reference><Reference><Citation>Preis A., et al. , Cryoelectron microscopic structures of eukaryotic translation termination complexes containing eRF1-eRF3 or eRF1-ABCE1. Cell Rep. 8, 59&#x2013;65 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6813808</ArticleId><ArticleId IdType="pubmed">25001285</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyers J. M., et al. , The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation. PLoS Pathog. 17, e1009412 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8513853</ArticleId><ArticleId IdType="pubmed">34597346</ArticleId></ArticleIdList></Reference><Reference><Citation>Hosokawa N., et al. , Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol. Biol. Cell 20, 1981&#x2013;1991 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2663915</ArticleId><ArticleId IdType="pubmed">19211835</ArticleId></ArticleIdList></Reference><Reference><Citation>Lipinski M. M., et al. , A genome-wide siRNA screen reveals multiple mTORC1 independent signaling pathways regulating autophagy under normal nutritional conditions. Dev. Cell 18, 1041&#x2013;1052 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2935848</ArticleId><ArticleId IdType="pubmed">20627085</ArticleId></ArticleIdList></Reference><Reference><Citation>Tidu A., et al. , The viral protein NSP1 acts as a ribosome gatekeeper for shutting down host translation and fostering SARS-CoV-2 translation. RNA 27, 253&#x2013;264 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7901841</ArticleId><ArticleId IdType="pubmed">33268501</ArticleId></ArticleIdList></Reference><Reference><Citation>DiGiuseppe S., Rollins M. G., Bartom E. T., Walsh D., ZNF598 plays distinct roles in interferon-stimulated gene expression and poxvirus protein synthesis. Cell Rep. 23, 1249&#x2013;1258 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5951170</ArticleId><ArticleId IdType="pubmed">29719242</ArticleId></ArticleIdList></Reference><Reference><Citation>Sundaramoorthy E., et al. , Ribosome quality control activity potentiates vaccinia virus protein synthesis during infection. J. Cell Sci. 134, jcs257188 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8106952</ArticleId><ArticleId IdType="pubmed">33912921</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhaddou M., et al. , The global phosphorylation landscape of SARS-CoV-2 infection. Cell 182, 685&#x2013;712.e19 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7321036</ArticleId><ArticleId IdType="pubmed">32645325</ArticleId></ArticleIdList></Reference><Reference><Citation>Bojkova D., et al. , Proteomics of SARS-CoV-2-infected host cells reveals therapy targets. Nature 583, 469&#x2013;472 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32408336</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., et al. , Ubiquitination of ABCE1 by NOT4 in response to mitochondrial damage links co-translational quality control to PINK1-directed mitophagy. Cell Metab. 28, 130&#x2013;144.e7 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5989559</ArticleId><ArticleId IdType="pubmed">29861391</ArticleId></ArticleIdList></Reference><Reference><Citation>Itzhak D. N., Tyanova S., Cox J., Borner G. H., Global, quantitative and dynamic mapping of protein subcellular localization. eLife 5, e16950 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4959882</ArticleId><ArticleId IdType="pubmed">27278775</ArticleId></ArticleIdList></Reference><Reference><Citation>Sliter D. A., et al. , Parkin and PINK1 mitigate STING-induced inflammation. Nature 561, 258&#x2013;262 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7362342</ArticleId><ArticleId IdType="pubmed">30135585</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C. C., Peterson A., Zinshteyn B., Regot S., Green R., Ribosome collisions trigger general stress responses to regulate cell fate. Cell 182, 404&#x2013;416.e14 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7384957</ArticleId><ArticleId IdType="pubmed">32610081</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan L. L., Zaher H. S., Ribosome quality control antagonizes the activation of the integrated stress response on colliding ribosomes. Mol. Cell 81, 614&#x2013;628.e4 (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7867595</ArticleId><ArticleId IdType="pubmed">33338396</ArticleId></ArticleIdList></Reference><Reference><Citation>Juszkiewicz S., et al. , Ribosome collisions trigger cis-acting feedback inhibition of translation initiation. eLife 9, e60038 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7381030</ArticleId><ArticleId IdType="pubmed">32657267</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickey K. L., et al. , GIGYF2 and 4EHP inhibit translation initiation of defective messenger RNAs to assist ribosome-associated quality control. Mol. Cell 79, 950&#x2013;962.e6 (2020).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7891188</ArticleId><ArticleId IdType="pubmed">32726578</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>